MedPath

LOIS: Long-Term Follow-Up in INSITE/SIFI

Completed
Conditions
Sacroiliac Joint Disruption
Degenerative Sacroilitis
Registration Number
NCT02270203
Lead Sponsor
SI-BONE, Inc.
Brief Summary

The purpose of this study is to evaluate the long term safety and effectiveness of SI joint fusion using the iFuse Implant System in patients with degenerative sacroiliitis (DS) and/or sacroiliac joint disruptions (SD).

Study Design: This study is extended follow-up from two ongoing multicenter prospective US clinical trials. All participants have already undergone the surgical procedure of interest (SI joint fusion with iFuse Implant System). The two ongoing trials are:

* SIFI:( Sacroiliac Joint Fusion with iFuse Implant System) a single-arm trial of patients with degenerative sacroiliitis or sacroiliac joint disruption who underwent iFuse placement, and

* INSITE(Investigation of Sacroiliac Fusion Treatment): a randomized clinical trial of the same patient population who underwent either non-surgical treatment or iFuse placement

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
103
Inclusion Criteria
  1. Patient enrolled and treated in SIFI or patient initially randomized to iFuse and treated in INSITE. Note: Patient may be in the initial follow up period associated with SIFI or INSITE at the same time they consent for this study and "extend" their post-operative follow up.
  2. Patient has signed study-specific LOIS informed consent form.
  3. Patient has the necessary mental capacity to participate and is physically able to comply with study protocol requirements.
Exclusion Criteria
  1. Treated with iFuse as a "crossover" in INSITE.
  2. Currently pregnant or planning pregnancy within 5 years of iFuse Implant.
  3. Patient is a prisoner or a ward of the state.
  4. Known or suspected active drug or alcohol abuse.
  5. Inadequately treated psychiatric illness (e.g., schizophrenia, major depression, personality disorders) that could interfere with study participation.
  6. Unwilling to perform the long-term follow up requirements of this study.
  7. Patient has any condition that could substantially prevent long-term follow-up.
  8. Unwilling to return to site at pre-specified study visits.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Subject Success3 years on LOIS (5 years post-op)

Composite endpoint of success defined as improvement in VAS (Visual Analog Scale) recorded at SIFI or INSITE Baseline VAS back pain score by ≥20 mm; Absence of device-related SAE (Serious Adverse Events) ; Absence of neurological worsening related to the sacral spine,\& Absence of surgical re-intervention on the target SI joint(s).

Radiographic (CT) apposition of bone to sacral and iliac sides of implant3 years on LOIS (5 years post-op)

Proportion of subjects (with CT) who had at least 30% apposition of bone to sacral and iliac sides in at least 2 of 3 iFuse implants.

Secondary Outcome Measures
NameTimeMethod
CT scans showing bridging bone3 years on LOIS (5 years post-op)

Proportion of CT scans that show bridging bone across the SI joint at 5 years post-operatively

SAE (Serious Adverse Events) occurrence rate3 years on LOIS

Occurrence rate of serious adverse events.

VAS (Visual Analog Scale)3 years on LOIS (5 years post-op)

Improvement in VAS (Visual Analog Scale), SI joint pain at follow-up visits.

Oswestry Disability Index (ODI) Questionnaire3 years on LOIS (5 years post-op)

Improvement in Oswestry Disability Index (ODI) at follow-up visits.

Improvement in quality of life (QOL)3 years on LOIS (5 years post-op)

Improvement in quality of life as measure by EQ-5D Questionnaire at follow-up visits.

non-working subjects returning to work3 years on LOIS (5 years post-op)

Proportion of non-working subjects who return to work

Trial Locations

Locations (12)

Yale University School of Medicine

🇺🇸

New Haven, Connecticut, United States

MUSC

🇺🇸

Charleston, South Carolina, United States

Integrated Spine Care

🇺🇸

Wauwatosa, Wisconsin, United States

Allegheny Medical Center

🇺🇸

Pittsburgh, Pennsylvania, United States

Regenerative Orthopaedics and Spine Institute

🇺🇸

Stockbridge, Georgia, United States

Orthopaedic Center of Southern Illinois

🇺🇸

Mount Vernon, Illinois, United States

Columbia Orthopaedic Group

🇺🇸

Columbia, Missouri, United States

Oklahoma Center for Spine & Pain Solutions

🇺🇸

Oklahoma City, Oklahoma, United States

Bluegrass Orthopaedics & Hand Care

🇺🇸

Lexington, Kentucky, United States

Precision Spine Care

🇺🇸

Tyler, Texas, United States

Overlake Hospital Medical Center

🇺🇸

Bellevue, Washington, United States

Aurora Research Institute

🇺🇸

Green Bay, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath